TITAN PHARMACEUTICALS
Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
- Conditions
- Interventions
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 6
- Registration Number
- NCT03250117
- Locations
- 🇺🇸
Orlando, Florida, Orlando, Florida, United States
🇺🇸Kirkland, Washington, Kirkland, Washington, United States
🇺🇸Farmington Hills, Michigan, Farmington Hills, Michigan, United States
A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
- Conditions
- Interventions
- First Posted Date
- 2014-07-03
- Last Posted Date
- 2019-01-11
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 177
- Registration Number
- NCT02180659
Re-Treatment Study of Probuphine in Opioid Addiction
- First Posted Date
- 2010-12-17
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 85
- Registration Number
- NCT01262261
- Locations
- 🇺🇸
Amit Vijapura, MD, Jacksonville, Florida, United States
🇺🇸Fidelity Clinical Research, Lauderhill, Florida, United States
🇺🇸Operation PAR, Inc. - TC Campus, Largo, Florida, United States
A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
- Conditions
- Interventions
- First Posted Date
- 2010-05-03
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 287
- Registration Number
- NCT01114308
- Locations
- 🇺🇸
BPRU, Behavioral Biology Research Center, Baltimore, Maryland, United States
🇺🇸David Geffen School of Medicine at UCLA, Los Angeles, California, United States
🇺🇸Friends Research Institute, Torrance, California, United States
Study of Probuphine in Patients With Opioid Dependence
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 16
- Registration Number
- NCT00772785
- Locations
- 🇺🇸
Scientific Clinical Research, Inc., North Miami, Florida, United States
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
- Conditions
- Interventions
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 9
- Registration Number
- NCT00768482
- Locations
- 🇺🇸
Segal Institute For Clinical Research, Fort Lauderdale, Florida, United States
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
- First Posted Date
- 2008-03-06
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 62
- Registration Number
- NCT00630201
- Locations
- 🇺🇸
Pahl Pharmaceutical Research, LLC, Oklahoma City, Oklahoma, United States
🇺🇸Amit Vijapura, MD, Jacksonville, Florida, United States
🇺🇸Behavioral Biology Research Unit, Johns Hopkins Bayview Campus, Baltimore, Maryland, United States
Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 163
- Registration Number
- NCT00447564
- Locations
- 🇺🇸
Duke University Medical Center Addictions Program, Durham, North Carolina, United States
🇺🇸Pahl Pharmaceutical Research, LLC, Oklahoma City, Oklahoma, United States
🇺🇸Synergy Clinical Research Center, National City, California, United States
Study of DITPA in Patients With Congestive Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2005-02-10
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 86
- Registration Number
- NCT00103519
- Locations
- 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸Saint Joseph's Research Institute, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
A Pilot Study of Pivanex in Patients With Malignant Melanoma
- Conditions
- First Posted Date
- 2004-07-13
- Last Posted Date
- 2005-08-30
- Lead Sponsor
- Titan Pharmaceuticals
- Target Recruit Count
- 14
- Registration Number
- NCT00087477
- Locations
- 🇺🇸
Mt. Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States